Local and Systemic Factors in the Pathogenesis of Osteoporosis

New England Journal of Medicine

Volumn 318, Issue 13, 1988, Pages 818-828

  Epstein, Franklin H ^a   Raisz, Lawrence G ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE DERIVED GROWTH FACTOR; CYTOKINE; PROSTAGLANDIN; TRANSFORMING GROWTH FACTOR BETA;

BONE METABOLISM; HUMAN; OSTEOPOROSIS; PATHOGENESIS; PRIORITY JOURNAL; SHORT SURVEY;

BONE AND BONES; HUMAN; OSTEOPOROSIS; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0023869716     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM198803313181305     Document Type: Review

References (132)

1. Cummings SR, Kelsey JL, Nevitt MC, O'Dowd KJ. Epidemiology of osteoporosis and osteoporotic fractures. Epidemiol Rev 1985; 7: 178–208.
2. Johnston CC, Norton J, Khairi MRA, et al. Heterogeneity of fracture syndromes in postmenopausal women. J Clin Endocrinol Metab 1985; 61: 551–6.
3. Melton LJ III, Wahner HW, Richelson LS, O'Fallon WM, Riggs BL. Osteoporosis and the risk of hip fracture. Am J Epidemiol 1986; 124: 254–61.
4. Raisz LG. Osteoporosis. J Am Geriatr Soc 1982; 30: 127–38.
5. Riggs BL, Melton LJ III. Involutional osteoporosis. N Engl J Med 1986; 314: 1676–86.
6. Riggs BL, Wahner HW, Melton LJ III, Richelson LS, Judd HL, Offord KP. Rates of bone loss in the appendicular and axial skeletons of women: evidence of substantial vertebral bone loss before menopause. J Clin Invest 1986; 77: 1487–91.
7. Dempster DW, Shane E, Horbert W, Lindsay R. A simple method for correlative light and scanning electron microscopy of human iliac crest bone biopsies: qualitative observations in normal and osteoporotic subjects. J Bone Miner Res 1986; 1: 15–21.
8. Cann CE, Genant HK, Kolb FO, Ettinger B. Quantitative computed tomography for prediction of vertebral fracture risk. Bone 1985; 6: 1–7.
9. Kleerekoper M, Villanueva AR, Stanciu J, Sudhaker Rao D, Parfitt AM. The role of three-dimensional trabecular microstructure in the pathogenesis of vertebral compression fractures. Calcif Tissue Int 1985; 37: 594–7.
10. Mosekilde L, Mosekilde L, Danielsen CC. Biomechanical competence of vertebral trabecular bone in relation to ash density and age in normal individuals. Bone 1987; 8: 79–85.
11. Ott SM, Kilcoyne RF, Chesnut CH III. Ability of four different techniques of measuring bone mass to diagnose vertebral fractures in postmenopausal women. J Bone Miner Res 1987; 2: 201–10.
12. Eriksen EF. Normal and pathological remodeling of human trabecular bone: three dimensional reconstruction of the remodeling sequence in normals and in metabolic bone disease. Endocr Rev 1986; 7: 379–408.
13. Hamilton JA, Lingelbach S, Partridge NC, Martin TJ. Regulation of plasminogen activator production by bone-resorbing hormones in normal and malignant osteoblasts. Endocrinology 1985; 116: 2186–91.
14. Chambers TJ, Darby JA, Fuller K. Mammalian collagenase predisposes bone surfaces to osteoclastic resorption. Cell Tissue Res 1985; 241: 671–5.
15. Shen V, Rifas L, Kohler G, Peck WA. Prostaglandins change cell shape and increase intercellular gap junctions in osteoblasts cultured from rat fetal calvaria. J Bone Miner Res 1986; 1: 243–9.
16. McSheehy PMJ, Chambers TJ. Osteoblast-like cells in the presence of parathyroid hormone release soluble factor that stimulates osteoclastic bone resorption. Endocrinology 1986; 119: 1654–9.
17. Baron R, Neff L, Van PT, Nefussi J-R, Vignery A. Kinetic and cytochemical identification of osteoclast precursors and their differentiation into multinucleated osteoclasts. Am J Pathol 1986; 122: 363–78.
18. Baron R, Neff L, Louvard D, Courtoy PJ. Cell-mediated extracellular acidification and bone resorption: evidence for a low pH in resorbing lacunae and localization of a 100-kD lysosomal membrane protein at the osteoclast ruffled border. J Cell Biol 1985; 101: 2210–22.
19. Parfitt AM. Trabecular bone architecture in the pathogenesis and prevention of fracture. Am J Med 1987; 82: 68–72.
20. Burr DB, Martin RB, Schaffler MB, Radin EL. Bone remodeling in response to in vivo fatigue microdamage. J Biochem 1985; 18: 189–200.
21. Brown JP, Delmas PD, Arlot M, Meunier PJ. Active bone turnover of the cortico-endosteal envelope in postmenopausal osteoporosis. J Clin Endocrinol Metab 1987; 64: 954–9.
22. Wong SYP, Kariks J, Evans RA, Dunstan CR, Hills E. The effect of age on bone composition and viability in the femoral head. J Bone Joint Surg [Am] 1985; 67: 274–83.
23. Forero MS, Klein RF, Nissenson RA, et al. Effect of age on circulating immunoreactive and bioactive parathyroid hormone levels in women. J Bone Miner Res 1987; 2: 363–6.
24. Young G, Marcus R, Minkoff JR, Kim LY, Segre GV. Age-related rise in parathyroid hormone in man: the use of intact and midmolecule antisera to distinguish hormone secretion from retention. J Bone Miner Res 1987; 2: 367–74.
25. Wilson R, Rao SD, Kleerekoper M, Parfitt AM. Is asymptomatic primary hyperparathyroidism (PHPT) a risk factor for vertebral compression fractures (VCF)? J Bone Miner Res 1987; 2: Suppl 1: S19. abstract.
26. Slovik DM, Rosenthal DI, Doppelt SH, et al. Restoration of spinal bone in osteoporotic men by treatment parathyroid hormone (1–34) and 1,25-dihydroxyvitamin D. J Bone Miner Res 1986; 1: 377–81.
27. Gunness-Hey M, Hock JM. Increased trabecular bone mass in rats treated with human synthetic parathyroid hormone. Metab Bone Dis Relat Res 1984; 5: 177–81.
28. Tsai K-S, Heath H III, Kumar R, Riggs BL. Impaired vitamin D metabolism with aging in women: possible role in pathogenesis of senile osteoporosis. J Clin Invest 1984; 73: 1668–72.
29. Peacock M, Hordon LH. Prevalence of osteomalacia and osteoporosis in femoral neck fracture. J Bone Miner Res 1987; 2: Suppl 1. abstract.
30. Gallagher JC, Jerpbak CM, Jee WSS, Johnson KA, DeLuca HF, Riggs BL. 1,25-Dihydroxyvitamin D3: short- and long-term effects on bone and calcium metabolism in patients with postmenopausal osteoporosis. Proc Natl Acad Sci USA 1982; 79: 3325–9.
31. Ott SM, Chesnut CH. Calcitriol treatment does not increase bone mass in postmenopausal osteoporotic women. J Bone Miner Res 1987; 2: Suppl 1: S29. abstract.
32. Hurley DL, Tiegs RD, Wahner HW, Heath H III. Axial and appendicular bone mineral density in patients with long-term deficiency or excess of calcitonin. N Engl J Med 1987; 317: 537–41.
33. Tiegs RD, Body JJ, Wahner HW, Barta J, Riggs BL, Heath H III. Calcitonin secretion in postmenopausal osteoporosis. N Engl J Med 1985; 312: 1097–100.
34. Beringer TRO, Ardill J, Taggart HM. Absence of evidence for a role of calcitonin in the etiology of femoral neck fracture. Calcif Tissue Int 1986; 39: 300–3.
35. Body J-J, Heath H III. Estimates of circulating monomeric calcitonin: physiological studies in normal and thyroidectomized man. J Clin Endocrinol Metab 1983; 57: 897–903.
36. Foresta C, Zanatta GP, Busnardo B, Scanelli G, Scandellari C. Testosterone and calcitonin plasma levels in hypogonadal osteoporotic young men. J Endocrinol Invest 1985; 8: 377–9.
37. Gruber HE, Ivey JL, Baylink DJ, et al. Long-term calcitonin therapy in postmenopausal osteoporosis. Metabolism 1984; 33: 295–303.
38. Hock JM, Centrella M, Canalis E. Insulin-like growth factor I has independent effects on bone matrix formation and cell replication. Endocrinology 1988; 122: 254–60.
39. Bennett AE, Wahner HW, Riggs BL, Hintz RL. Insulin-like growth factors I and II: aging and bone density in women. J Clin Endocrinol Metab 1984; 59: 701–4.
40. Schlechter NL, Russell SM, Spencer EM, Nicoll CS. Evidence suggesting that the direct growth-promoting effect of growth hormone on cartilage in vivo is mediated by local production of somatomedin. Proc Natl Acad Sci USA 1986; 83: 7932–4.
41. Raisz LG. Effect of corticosteroids on calcium metabolism. Prog Biochem Pharmacol 1980; 17: 212–9.
42. Chyun YS, Kream BE, Raisz LG. Cortisol decreases bone formation by inhibiting periosteal cell proliferation. Endocrinology 1984; 114: 477–80.
43. Auwerx J, Bouillon R. Mineral and bone metabolism in thyroid disease: a review. Q J Med 1986; 60: 737–52.
44. Coindre J-M, David J-P, Rivière L, et al. Bone loss in hypothyroidism with hormone replacement: a histomorphometric study. Arch Intern Med 1986; 146: 48–53.
45. Kream BE, Smith MD, Canalis E, Raisz LG. Characterization of the effect of insulin on collagen synthesis in fetal rat bone. Endocrinology 1985; 116: 296–302.
46. Hui SL, Epstein S, Johnston CC Jr. A prospective study of bone mass in patients with type I diabetes. J Clin Endocrinol Metab 1985; 60: 74–80.
47. Heath H III, Melton LJ III, Chu C-P. Diabetes mellitus and risk of skeletal fracture. N Engl J Med 1980; 303: 567–70.
48. Francis RM, Peacock M, Aaron JE, et al. Osteoporosis in hypogonadal men: role of decreased plasma 1,25-dihydroxyvitamin D, calcium malabsorption, and low bone formation. Bone 1986; 7: 261–8.
49. Jackson JA, Kleerekoper M, Parfitt AM, Rao DS, Villanueva AR, Frame B. Bone histomorphometry in hypogonadal and eugonadal men with spinal osteoporosis. J Clin Endocrinol Metab 1987; 65: 53–8.
50. Selby PL, Peacock M, Barkworth SA, Brown WB, Taylor GA. Early effects of ethinyloestradiol and norethisterone treatment in post-menopausal women on bone resorption and calcium regulating hormones. Clin Sci 1985; 69: 265–71.
51. Christiansen C, Riis BJ, Nilas L, R⊘dbro P, Deftos L. Uncoupling of bone formation and resorption by combined oestrogen and progestagen therapy in postmenopausal osteoporosis. Lancet 1985; 2: 800–1.
52. Malluche HH, Faugere M-C, Rush M, Friedler R. Osteoblastic insufficiency is responsible for maintenance of osteopenia after loss of ovarian function in experimental Beagle dogs. Endocrinology 1986; 119: 2649–54.
53. Selby PL, Peacock M. Ethinyl estradiol and norethindrone in the treatment of primary hyperparathyroidism in postmenopausal women. N Engl J Med 1986; 314: 1481–5.
54. Klibanski A, Greenspan SL. Increase in bone mass after treatment of hyperprolactinemic amenorrhea. N Engl J Med 1986; 315: 542–6.
55. Falch JA, Oftebro H, Haug E. Early postmenopausal bone loss is not associated with a decrease in circulating levels of 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D, or vitamin D-binding protein. J Clin Endocrinol Metab 1987; 64: 836–41.
56. Eriksen EF, Berg NJ. Graham ML, Mann KG, Speisbert TC, Riggs BL. Evidence of estrogen receptors in human bone cells. J Bone Miner Res 1987; 2: Suppl 1: S31. abstract.
57. Komm BS, Sheetz L, Baker M, Gallegos A, O'Malley BW, Haussler MR. Bone related cells in culture express putative estrogen receptor mRNA and l25I–17β-estradiol binding. J Bone Miner Res 1987; 2: Suppl 1: S31. abstract.
58. Morel G, Boivin G, David L, Dubois PM, Meunier PJ. Immunocytochemical evidence for endogenous calcitonin and parathyroid hormone in osteoblasts from the calvaria of neonatal mice: absence of endogenous estradiol and estradiol receptors. Cell Tissue Res 1985; 240: 89–93.
59. Ettinger B, Genant HK, Cann CE. Long-term estrogen replacement therapy prevents bone loss and fractures. Ann Intern Med 1985; 102: 319–24.
60. Wolff J. The law of bone remodelling. Berlin: Springer-Verlag, 1987; 1–125.
61. Urist MR, DeLange RJ, Finerman GAM. Bone cell differentiation and growth factors. Science 1983; 220: 680–6.
62. Hauschka PV, Mavrakos AE, Iafrati MD, Doleman SE, Klagsbrun M. Growth factors in bone matrix: isolation of multiple types by affinity chromatography on heparin-sepharose. J Biol Chem 1986; 261: 12665–74.
63. Heldin C-H, Johnsson A, Wennergren S, Wernstedt C, Betsholtz C, Westermark B. A human osteosarcoma cell line secretes a growth factor structurally related to a homodimer of PDGF A-chains. Nature 1986; 319: 511–4.
64. Triffitt JT, Owen ME, Ashton BA, Wilson JM. Plasma disappearance of rabbit alpha 2 HS-glycoprotein and its uptake by bone tissue. Calcif Tissue Int 1978; 26: 155–61.
65. Moseley JM, Kubota M, Diefenbach-Jagger H, et al. Parathyroid hormone-related protein purified from a human lung cancer cell line. Proc Natl Acad Sci USA 1987; 84: 5048–52.
66. Suva LJ, Winslow GA, Wettenhall REH, et al. A parathyroid hormone-related protein implicated in malignant hypercalcemia: cloning and expression. Science 1987; 237: 893–6.
67. Raisz LG, Martin TJ. Prostaglandins in bone and mineral metabolism. In: Peck WA, ed. Bone and mineral research, annual 2. Amsterdam: Excerpta Medica, 1984:286–310.
68. Lerner UH, Ransjö M, Ljunggren Ö. Prostaglandin E2 causes a transient inhibition of mineral mobilization, matrix degradation, and lysosomal enzyme release from mouse calvarial bones in vitro. Calcif Tissue Int 1987; 40: 323–31.
69. Raisz LG, Kream BE. Regulation of bone formation. N Engl J Med 1983; 309: 29–35.
70. Raisz. Regulation of bone formation. N Engl J Med 1983; 309: 83–9.
71. Raisz LG, Sandberg AL, Goodson JM, Simmons HA, Mergenhagen SE. Complement-dependent stimulation of prostaglandin synthesis and bone resorption. Science 1974; 185: 789–91.
72. Tashjian AH Jr, Voelkel EF, Lazzaro M, Goad D, Bosma T, Levine L. Tumor necrosis factor-α (cachectin) stimulates bone resorption in mouse calvaria via a prostaglandin-mediated mechanism. Endocrinology 1987; 120: 2029–36.
73. Tashjian AH, Voelkel EF, Lazzaro M, et al. α and β human transforming growth factors stimulate prostaglandin production and bone resorption in cultured mouse calvaria. Proc Natl Acad Sci USA 1985; 82: 4535–8.
74. Lerner UH, Jones IL, Gustafson GT. Bradykinin, a new potential mediator of inflammation-induced bone resorption: studies of the effects on mouse calvarial bones and articular cartilage in vitro. Arthritis Rheum 1987; 30: 530–40.
75. Hoffmann O, Klaushofer K, Koller K, Peterlik M, Mavreas T, Stern P. Indomethacin inhibits thrombin-, but not thyroxin- stimulated resorption of fetal rat limb bones. Prostaglandins 1986; 31: 601–8.
76. Raisz LG, Simmons HA. Effects of parathyroid hormone and cortisol on prostaglandin production by neonatal rat calvaria in vitro. Endocr Res 1985; 11: 59–74.
77. Somjen D, Binderman I, Berger E, Harell A. Bone remodelling induced by physical stress is prostaglandin E2 mediated. Biochem Biophys Acta 1980; 627: 91–100.
78. Rodan SB, Wesolowski G, Rodan GA. Clonal differences in prostaglandin synthesis among osteosarcoma cell lines. J Bone Miner Res 1986; 1: 213–20.
79. Nolan RD, Partridge NC, Godfrey HM, Martin TJ. Cyclo-oxygenase products of arachidonic acid metabolism in rat osteoblasts in culture. Calcif Tissue Int 1983; 35: 294–7.
80. Feyen JHM, Raisz LG. Prostaglandin production by calvariae from sham operated and oophorectomized rats: effect of 17β-estradiol in vivo. Endocrinology 1987; 121: 819–21.
81. Wronski TJ, Walsh CC, Ignaszewski LA. Histologic evidence for osteopenia and increased bone turnover in ovariectomized rats. Bone 1986; 7: 119–23.
82. Turner RT, Vandersteenhoven JJ, Bell NH. The effects of ovariectomy and 17β-estradiol on cortical bone histomorphometry in growing rats. J Bone Miner Res 1987; 2: 115–22.
83. Jeffcoat MK, Williams RC, Wechter WJ, et al. Flurbiprofen treatment of periodontal disease in beagles. J Periodont Res 1986; 21: 624–33.
84. Thompson DD, Rodan GA. Immobilization produces increased bone resorption and decreased formation in rats. J Bone Miner Res 1986; 1: Suppl 1: S23. abstract.
85. Wientroub S, Wahl LM, Feuerstein N, Winter CC, Reddi AH. Changes in tissue concentration of prostaglandins during endochondral bone differentiation. Biochem Biophys Res Commun 1983; 117: 746–50.
86. Elmstedt E, Lindholm TS, Nilsson OS, Törnkvist H. Effect of ibuprofen on heterotopic ossification after hip replacement. Acta Orthop Scand 1985; 56: 25–7.
87. Jee WSS, Ueno K, Deng YP, Woodbury DM. The effects of prostaglandin E2 in growing rats: increased metaphyseal hard tissue and cortico-endosteal bone formation. Calcif Tissue Int 1985; 37: 148–57.
88. Horton JE, Raisz LG, Simmons HA, Oppenheim JJ, Mergenhagen SE. Bone resorbing activity in supernatant fluid from cultured human peripheral blood leukocytes. Science 1972; 177: 793–5.
89. Dewhirst FE, Stashenko PP, Mole JE, Tsurumachi T. Purification and partial sequence of human osteoclast-activating factor: identity with interleukin 1β. J Immunol 1985; 135: 2562–8.
90. Lorenzo JA, Sousa SL, Alander C, Raisz LG, Dinarello CA. Comparison of the bone-resorbing activity in the supernatants from phytohemagglutinin-stimulated human peripheral blood mononuclear cells with that of cytokines through the use of an antiserum to interleukin 1. Endocrinology 1987; 121: 1164–70.
91. Gowen M, Mundy GR. Actions of recombinant interleukin 1, interleukin 2, and interferon-γ on bone resorption in vitro. J Immunol 1986; 136: 2478–82.
92. Bertolini DR, Nedwin GE, Bringman TS, Smith DD, Mundy GR. Stimulation of bone resorption and inhibition of bone formation in vitro by human tumour necrosis factors. Nature 1986; 319: 516–8.
93. Canalis E. Interleukin-1 has independent effects on deoxyribonucleic acid and collagen synthesis in cultures of rat calvariae. Endocrinology 1986; 118: 74–81.
94. Smith DD, Gowen M, Mundy GR. Effects of interferon-γ and other cytokines on collagen synthesis in fetal rat bone cultures. Endocrinology 1987; 120: 2494–9.
95. Dewhirst FE, Ago JM, Peros WJ, Stashenko P. Synergism between parathyroid hormone and interleukin-1 in stimulating bone resorption in organ culture. J Bone Miner Res 1987; 2: 127–34.
96. Lorenzo JA, Sousa S. Interleukin-1 synergistically enhances bone resorption stimulated by transforming growth factor alpha in fetal rat long bone cultures through prostaglandin synthesis. J Bone Miner Res 1987; 2: Suppl 1: S42:376. abstract.
97. Hanazawa S, Amano S, Nakada K, et al. Biological characterization of interleukin-1-like cytokine produced by cultured bone cells from newborn mouse calvaria. Calcif Tissue Int 1987; 41: 31–7.
98. Gowen M, Nedwin G, Mundy GR. Preferential inhibition of cytokine stimulated bone resorption by recombinant interferon gamma. J Bone Miner Res 1986; 1: 469–74.
99. Takahashi N, Mundy GR, Roodman GD. Recombinant human interferon-γ inhibits formation of human osteoclast-like cells. J Immunol 1986; 137: 3544–9.
100. Peterlik M, Hoffmann O, Swetly P, Klaushofer K, Koller K. Recombinant γ-interferon inhibits prostaglandin-mediated and parathyroid hormone-induced bone resorption in cultured neonatal mouse calvaria. FEBS Lett 1985; 185: 287–90.
101. MacDonald GR, Mundy GR, Clark S, et al. Effects of human recombinant CSF-GM and highly purified CSF-1 on the formation of multinucleated cells with osteoclast characteristics in long-term bone marrow cultures. J Bone Miner Res 1986; 1: 227–33.
102. Lorenzo JA, Sousa SL, Fonseca JM, Hock JM, Medlock ES. Colony-stimulating factors regulate the development of multinucleated osteoclasts from recently replicated cells in vitro. J Clin Invest 1987: 160–4.
103. Garrett IR, Durie BGM, Nedwin GE, et al. Production of lymphotoxin, a bone-resorbing cytokine, by cultured human myeloma cells. N Engl J Med 1987; 317: 526–32.
104. Pacifici R, Rifas L, Teitelbaum S, et al. Spontaneous release of interleukin 1 from human blood monocytes reflects bone formation in idiopathic osteoporosis. Proc Natl Acad Sci USA 1987; 84: 4616–20.
105. Fujita T, Matsui T, Nakao Y, Watanabe S. T lymphocyte subsets in osteoporosis: effect of 1-alpha hydroxyvitamin D3. Miner Electrolyte Metab 1984; 10: 375–8.
106. Rosen CR, Owens M, Adler RA. Altered lymphocyte subsets in postmenopausal osteoporosis. J Bone Miner Res 1987; 2: Suppl 1. abstract.
107. Canalis E, McCarthy T, Centrella M. Isolation and characterization of insulin-like growth factor I (somatomedin C) from cultures of fetal rat calvariae. Endocrinology 1988; 122: 22–7.
108. Ernst M, Froesch ER. Growth hormone (GH) dependent stimulation of rat osteoblasts in culture is mediated partially by local synthesis of immuno-reactive insulin-like growth factor (IGF) I. J Bone Miner Res 1987; 2: Suppl 1: S13. abstract.
109. Seyedin SM, Thoms TC, Thompson AY, Rosen DM, Piez KA. Purification and characterization of two cartilage-inducing factors from bovine demineralized bone. Proc Natl Acad Sci USA 1985; 82: 2267–71.
110. Seyedin SM, Thompson AY, Bentz H, et al. Cartilage-inducing factor-A: apparent identity to transforming growth factor-β. J Biol Chem 1986; 261: 5693–5.
111. Centrella M, McCarthy TL, Canalis E. Transforming growth factor-β is a bifunctional regulator of replication and collagen synthesis in osteoblast-enriched cell cultures from fetal rat bone. J Biol Chem 1987; 262: 2869–74.
112. Centrella. Mitogenesis in fetal rat bone cells simultaneously exposed to type β transforming growth factor and other growth regulators. FASEB J 1987; 1: 312–7.
113. Chenu C, Pfeilschifter J, Mundy GR, Roodman GR. Transforming growth factor-β inhibits formation of osteoclast-like cells in long-term human marrow cultures. J Bone Miner Res 1987; 2: Suppl 1. abstract.
114. Pfeilschifter J, Mundy GR. Modulation of type β transforming growth factor activity in bone cultures by osteotropic hormones. Proc Natl Acad Sci USA 1987; 84: 2024–8.
115. Mohan S, Linkhart T, Jennings J, Baylink D. Chemical and biological characterization of low-molecular-weight human skeletal growth factor. Biochim Biophys Acta 1986; 884: 243–50.
116. Canalis E, McCarthy T, Centrella M. A bone-derived growth factor isolated from rat calvariae is beta2 microglobulin. Endocrinology 1987; 121: 1198–200.
117. Linkhart S, Mohan S, Linkhart TA, Kumegawa M, Baylink DJ. Human skeletal growth factor stimulates collagen synthesis and inhibits proliferation in a clonal osteoblast cell line (MC3T3–E1). J Cell Physiol 1986; 128: 307–12.
118. Canalis E, Lorenzo J, Burgess WH, Maciag T. Effects of endothelial cell growth factor on bone remodelling in vitro. J Clin Invest 1987; 79: 52–8.
119. Ibbotson KJ, Harrod J, Gowen M, et al. Human recombinant transforming growth factor α stimulates bone resorption and inhibits formation in vitro. Proc Natl Acad Sci USA 1986; 83: 2228–32.
120. Thomas KA, Gimenez-Gallego G. Fibroblast growth factors: broad spectrum mitogens with potent angiogenic activity. Trends Biochem Sci 1986; 11: 81–4.
121. Schreiber AB, Winkler ME, Derynck R. Transforming growth factor-α: a more potent angiogenic mediator than epidermal growth factor. Science 1986; 232: 1250–3.
122. Paterson CR, McAllion S, Stellman JL. Osteogenesis imperfecta after the menopause. N Engl J Med 1984; 310: 1694–6.
123. Fisher LW, Termine JD. Noncollagenous proteins influencing the local mechanisms of calcification. Clin Orthop 1985; 200: 362–85.
124. Wu CH, Donovan CB, Wu GY. Evidence for pretranslational regulation of collagen synthesis by procollagen propeptides. J Biol Chem 1986; 261: 10482–4.
125. Delmas PD, Malaval L, Arlot ME, Meunier PJ. Serum bone Gla-protein compared to bone histomorphometry in endocrine diseases. Bone 1985; 6: 339–41.
126. Skj⊘dt H, Gallagher JA, Beresford JN, Couch M, Poser JW, Russell RGG. Vitamin D metabolites regulate osteocalcin synthesis and proliferation of human bone cells in vitro. J Endocrinol 1985; 105: 391–6.
127. Stenner DD, Tracy RP, Riggs BL, Mann KG. Human platelets contain and secrete osteonectin. Proc Natl Acad Sci USA 1986; 83: 6892–6.
128. Delmas PD, Wahner HW, Mann KG, Riggs BL. Assessment of bone turnover in postmenopausal osteoporosis by measurement of serum bone Gla-protein. J Lab Clin Med 1983; 102: 470–6.
129. Burtis WJ, Wu T, Bunch C, et al. Identification of a novel 17,000-dalton parathyroid hormone-like adenylate cyclase-stimulating protein from a tumor associated with humoral hypercalcemia of malignancy. J Biol Chem 1987; 262: 7151–6.
130. Merendino JJ Jr, Insogna KL, Milstone LM, Broadus AE, Stewart AF. A parathyroid hormone–like protein from cultured human keratinocytes. Science 1986; 231: 388–90.
131. McKenna MJ, Frame B. The mast cell and bone. Clin Orthop 1985; 200: 226–33.
132. Hurley MM, Kream BE, Raisz LG. Effects of heparin on cultured 21-day fetal rat calvaria. J Bone Miner Res 1987; 2: Suppl 1: S14. abstract.